Additive effect of erythropoietin use on exercise-induced endothelial activation and hypercoagulability in athletes

PURPOSE: Recombinant human erythropoietin (rHuEPO) is known to increase thrombotic risk in patients and might have similar effects in athletes abusing the drug. rHuEPO is prohibited by anti-doping legislation, but this risk has not been investigated thoroughly. This analysis was designed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Heuberger, Jules A. A. C., Posthuma, Jelle J., Ziagkos, Dimitrios, Rotmans, Joris I., Daniels, Johannes M. A., Gal, Pim, Stuurman, Frederik E., Spronk, Henri M. H., Ten Cate, Hugo, Burggraaf, Jacobus, Moerland, Matthijs, Cohen, Adam F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340646/
https://www.ncbi.nlm.nih.gov/pubmed/32537688
http://dx.doi.org/10.1007/s00421-020-04419-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340646/
https://www.ncbi.nlm.nih.gov/pubmed/32537688
http://dx.doi.org/10.1007/s00421-020-04419-0

Ejemplares similares